GH1 and cardiovascular disorder: Despite limited data showing low rates of cardiovascular events and no change in left ventricular wall thickness with GH treatment, some concerns persist about the role of GH in progression of cardiovascular disease in patients with NS (8, 9, 10, 11, 12, 13, 14, 15, 16, 17).